Role of innate and adaptive cytokines in the survival of COVID-19 patients

J Monserrat, A Gómez-Lahoz, MA Ortega… - International journal of …, 2022 - mdpi.com
SARS-CoV-2 is a new coronavirus characterized by a high infection and transmission
capacity. A significant number of patients develop inadequate immune responses that …

Plasma cytokines in patients with COVID-19 during acute phase of the disease and following complete recovery

N Arsentieva, N Liubimova, O Batsunov, Z Korobova… - 2021 - covid19.neicon.ru
COVID-19, an infection caused by the new coronavirus SARS-CoV-2, is associated with a
number of pathophysiological mechanisms, mobilizing a wide spectrum of biomolecules …

The potential predictive role of tumour necrosis factor-α, interleukin-1β, and monocyte chemoattractant protein-1 for COVID-19 patients survival

K Kumboyono, IN Chomsy, A Iskandar… - Infection and Drug …, 2022 - Taylor & Francis
Background Tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and monocyte
chemoattractant protein-1 (MCP-1) are early phase cytokines often encountered when the …

The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical)

M Ghofrani Nezhad, G Jami, O Kooshkaki… - Journal of Interferon & …, 2023 - liebertpub.com
Cytokine storm refers to the overproduction of immune and inflammatory cells and their
proteins (cytokines)[interleukin (IL)-1 and IL-6] causing acute respiratory distress syndrome …

Cytokines from bench to bedside: A retrospective study identifies a definite panel of biomarkers to early assess the risk of negative outcome in COVID-19 patients

M Fabris, F Del Ben, E Sozio, AP Beltrami… - International Journal of …, 2022 - mdpi.com
The main aim of this study was to identify the most relevant cytokines which, when assessed
in the earliest stages from hospital admission, may help to select COVID-19 patients with …

Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection

AS Tripathy, S Vishwakarma, D Trimbake, YK Gurav… - Archives of …, 2021 - Springer
Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …

A deep look into COVID-19 severity through dynamic changes in blood cytokine levels

DA Kleymenov, EN Bykonia, LI Popova… - Frontiers in …, 2021 - frontiersin.org
An excessive inflammatory response to SARS-CoV-2 is thought to be a major cause of
disease severity and mortality in patients with COVID-19. Longitudinal analysis of cytokine …

Analysis of plasma proteins involved in inflammation, immune response/complement system, and blood coagulation upon admission of COVID-19 patients to hospital …

DC Di Flora, A Dionizio, HABS Pereira, TF Garbieri… - Cells, 2023 - mdpi.com
The development of new approaches allowing for the early assessment of COVID-19 cases
that are likely to become critical and the discovery of new therapeutic targets are urgently …

[HTML][HTML] Role of tumor necrosis factor-α in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia

F Jia, G Wang, J Xu, J Long, F Deng, W Jiang - Aging (Albany NY), 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) is presently the most pressing public
health concern worldwide. Cytokine storm is an important factor leading to death of patients …

Distinct patterns of blood cytokines beyond a cytokine storm predict mortality in COVID-19

C Herr, S Mang, B Mozafari, K Guenther… - Journal of …, 2021 - Taylor & Francis
Background COVID-19 comprises several severity stages ranging from oligosymptomatic
disease to multi-organ failure and fatal outcomes. The mechanisms why COVID-19 is a mild …